OTC Healthcare - South Korea
OTC Healthcare in South Korea : Market Insight
EXECUTIVE SUMMARY
Slowdown in 2006 Increasing health concerns drive sales growth Vitamins and dietary supplements remains the largest product group Rapid growth of Rx industry hinders the growth of OTC Moderate forecast value growth is expected KEY TREND AND DEVELOPMENTS
Rx continues to record faster growth than OTC Wellbeing trend leads to positive sales growth of OTC healthcare Established brands consolidate their positions Declining birth rate affects demand for child-specific OTC healthcare Growing importance of retail grocery channels Growing number of entries leads to fragmentation MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - South Korea
Daewoong Pharmaceutical Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2006
Dong Wha Pharmaceutical Industrial Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 6 Dong Wha Pharmaceutical Ind. Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Ind. Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 8 Dong Wha Pharmaceutical Ind. Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 9 Dong Wha Pharmaceutical Ind. Co Ltd: Competitive Position 2006
Dong-A Pharmaceutical Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2006
Korea Ginseng Corp - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 14 Korea Ginseng Corp: Key Facts
Summary 15 Korea Ginseng Corp: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 16 Korea Ginseng Corp: Production Statistics
COMPETITIVE POSITIONING
Summary 17 Korea Ginseng Corp: Competitive Position 2006
SK Chemicals Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 18 SK Chemicals Co Ltd: Key Facts
Summary 19 SK Chemicals: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 20 SK Chemicals Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 21 SK Chemicals Co Ltd: Competitive Position 2006
Wound treatments in South Korea
HEADLINES
SECTOR DATA
Table 11 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 13 Wound Treatments Company Shares by Retail Value 2002-2006
Table 14 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
